Polestar nearly revenue doubles in the first six months of 2022 https://t.co/wIdaTijsv2

Polestar nearly revenue doubles in the first six months of 2022 https://t.co/wIdaTijsv2
http://dlvr.it/SYHW07

Comments

Post a Comment

Popular posts from this blog

#Columbia Sportswear Appoints Cory Long as New President of SOREL Brand

Image
Columbia Sportswear Company has named Cory Long as the new President of the SOREL brand, a significant move that brings in a seasoned expert to lead the brand. Long, previously the Global General Manager and Chief Global Merchant of DC Shoes, boasts extensive experience in the footwear and apparel industry. His appointment signals the company's commitment to driving SOREL's growth and solidifying its position in the market. This strategic decision is poised to shape the future trajectory of the brand and the company's overall standing in the global active lifestyle apparel and footwear industry. Cory Long Takes the Helm as SOREL's New President Cory Long, a seasoned professional in the footwear and apparel industry, has been appointed as the new president of the SOREL brand. Long brings a wealth of experience and expertise to his new role, having served as the global general manager and chief global merchant of DC Shoes. His distinguished career includes leaders
Read more

Venture Capital Firms in San Francisco

Image
  Venture Capital Firms in San Francisco The following list of notable venture capital firms in San Francisco is dynamic and likely to never be complete. Please consider adding additional items and reliable sources. For example, you can read a press release from Preqin Special Report to see if your company's idea would make it into their portfolio. Or, check out this list of notable venture capital firms in San Francisco, CA to see what your business might need to be successful. Foresite Capital invests in healthcare Foresite Capital is a venture capital firm that invests in healthcare startups. It recently raised $969 million in a fund to support healthcare startups. The new fund is its largest to date, with nearly triple the target amount. The firm's CEO, Dr. Jim Tananbaum, says that he's excited about the sector because of the promise it offers to patients. The company has invested in startups in all stages of development, from seed stage to later-stage, and has over
Read more